Introduction {#sec1}
============

Known bacteria of the genus *Actinomyces* are all Gram positive. The majority are facultative anaerobes, but some are strict anaerobes. Members of the genus *Actinomyces* have a high DNA G+C content [@bib1]. The genus *Actinomyces* was first established in 1877 by Harz and colleagues as a member of the *Actinobacteria* phylum [@bib2]. The first isolated species of this genus was *Actinomyces bovis* [@bib3]. Today 47 species have been identified with validly published names with standing in nomenclature. The number of discovered *Actinomyces* species increased considerably from the 1980s, corresponding with the start of utilization of PCR ([Fig. 1](#fig1){ref-type="fig"}). This date was a turning point in the characterization of *Actinomyces* species, which now is not just only based on phenotypic observation but also on genetic analysis. Now, the development of quick and low-price genome sequencing and annotating allow us to go further in the characterization of bacterial species. *Actinomyces* species are known to be ubiquitous, colonizing soil, animals or humans. In humans, they are particularly present in the oral mucosa or urogenital and intestinal tracts [@bib4]. Several of them, such as *Actinomyces israeli* [@bib5], [@bib6], [@bib7], are present in the ground and can play an important role in the decomposition of organic matter and biotechnologic studies. However, bacteria of the genus *Actinomyces* are also part of the normal flora of the oral cavity and respiratory tract, and can be implicated in blood and organ infections [@bib8], [@bib9].Fig. 1Identification of *Actinomyces* new species since first one, *Actionmyces bovis,* was described by Harz and collaborators in 1877 [@bib3].Fig. 1

In this study, we used a new approach, including matrix-assisted desorption ionization--time of flight mass spectrometry (MALDI-TOF MS), phenotypic description and genome sequencing [@bib10], [@bib11], [@bib12], [@bib13], [@bib14] to describe six new *Actinomyces* species: *Actinomyces ihuae* strain SD1, *Actinomyces bouchesdurhonensis* strain Marseille-P2825, *Actinomyces urinae* strain Marseille-P2225, *Actinomyces marseillensis* strain Marseille-P2818, *Actinomyces mediterranea* strain Marseille-P3257 and *Actinomyces oralis* strain Marseille-P3109. These are all Gram positive, rod shaped and facultative aerobic. They were respectively isolated from sputum sample of healthy persons living in Marseille (France) (*A. marseillensis* and *A. oralis*), stool sample of an HIV-infected man (*A. ihuae*), urine sample of a girl with nephrotic syndrome (*A. urinae*), duodenum wash sample of a woman with oesophagitis (*A. mediterranea*) and stomach wash sample of a man with iron-deficiency anaemia (*A. bouchesdurhonensis*) ([Table 1](#tbl1){ref-type="table"}). These new bacterial species were part of a culturomics study which aimed to explore the diversity in the whole human microbiota using multiple culture conditions [@bib15], [@bib16].Table 1Sample informationTable 1CharacteristicABCDEFSample originHuman stomach washHuman stoolHuman sputumHuman duodenum washHuman sputumHuman urinePatient information60-year-old man with iron-deficiency anaemia50-year-old HIV-infected manHealthy Marseille woman76-year-old woman with oesophagitisHealthy Marseille man13-year-old girl with nephritic syndromeAuthorization/consentNo. 09-022 (IFR 48, Marseille)No. 09-022 (IFR 48, Marseille)No. 09-022 (IFR 48, Marseille)No. 09-022 (IFR 48, Marseille)No. 09-022 (IFR 48, Marseille)No. 09-022 (IFR 48, Marseille) consent of girl\'s parentsStorage−80°C−80°C−80°C−80°C−80°C−80°CIsolation conditionsCOS medium day 3 anaerobic 37°CCOS medium day 2 microaerobic 37°CHaemoculture + rumen day 30 anaerobic 30°CHaemoculture + rumen + sang day 7 anaerobic 37°CHaemoculture + rumen day 15 aerobic 37°CHaemoculture + rumen day 10 anaerobic 37°C[^1]

On the basis of the results of phenotypic, genomic and phylogenetic analyses, these strains are considered to represent new species of the *Actinomyces* genus. However, our study uses a new concept of bacterial description combining a proteomics analysis with the MALDI-TOF MS profile [@bib17] associated with phenotypic and genomic descriptions of these six new species.

Here we present a summary of classification, main features and complete genomic sequencing and annotation of the present type strains of these six *Actinomyces* new species: *Actinomyces ihuae* strain SD1 (= CSUR P2006 = DSM 100538), *Actinomyces bouchesdurhonensis* strain Marseille-P2825 (= CSUR P2825 = DSM 103075), *Actinomyces urinae* strain Marseille-P2225 (= CSUR P2225 = DSM 100700), *Actinomyces marseillensis* strain Marseille-P2818 (= CSUR P2818 = CCUG 71898), *Actinomyces mediterranea* strain Marseille-P3257 (= CSUR P3257 = CCUG 70143) and *Actinomyces oralis* strain Marseille-P3109 (= CSUR P3109 = DSM 103942). These characteristics support the creation of these six new species.

Materials and methods {#sec1.1}
---------------------

### Strain identification and phylogenetic analysis {#sec1.1.1}

Culturomics methodology, previously described by Lagier *et al*. [@bib18], doubles the number of bacteria species isolated at least once from the human gut [@bib16]. We used this methodology to isolate these strains from several diverse human samples. Samples, conditions of isolation and origins are summarized in [Table 1](#tbl1){ref-type="table"}. All patients provided informed consent, and the study was validated by the ethics committee of the Institut Fédératif de Recherche 48, Faculty of Medicine, Marseille, France, under agreement 09-022.

Purified colonies were identified by MALDI-TOF MS using a Microflex LT spectrometer and a MSP 96 MALDI-TOF target plate (Bruker Daltonics, Bremen, Germany), as previously described [@bib17]. The obtained spectra were imported into MALDI Biotyper 3.0 software (Bruker) and analysed by standard pattern matching (with default parameter settings) against the main spectra of the 7537 bacteria included in the databases (constantly updated Bruker and Unité des Maladies Infectieuses et Tropicales Emergentes (URMITE) databases). The resulting score enabled the identification (or not) of tested species: a score of ≥2 with a validly published species enabled identification at the species level; a score of ≥1.7 but \<2 enabled identification at the genus level; and a score of \<1.7 did not enable any identification. Any significant score has been obtained for our six strains, suggesting that the isolates were not members of known species.

We thus realized sequencing of 16S rRNA genes in order to identify these strains. DNA was previously extracted by EZ1 DNA Tissue Kit using BioRobot EZ1 Advanced XL (Qiagen, Courtaboeuf, France). The amplification and purification of the 16S rRNA gene was done as previously described by using the universal primer pair fD1 and rP2 (Eurogentec, Angers, France). Sequencing was then done using the Big Dye Terminator v1.1 Cycle Sequencing Kit and ABI Prism 3130xl Genetic Analyzer capillary sequencer (Applied Biosystems; Thermo Fisher Scientific, Waltham, MA, USA), as previously described [@bib19]. The 16S rRNA nucleotide sequences were assembled and corrected using CodonCode Aligner software (<http://www.codoncode.com>), and BLASTn searches were performed against the GenBank National Center for Biotechnology Information (NCBI) database (<http://blast.ncbi.nlm.nih.gov.gate1.inist.fr/Blast.cgi>) to determine the percentage of similarity with the closest bacteria. A similarity threshold \<98.7% allows the definition of a new species, whereas a threshold \<95% allows the definition of a new genus without performing DNA-DNA hybridization [@bib20]. A custom Python script was used to automatically retrieve all species from the same family of the new species and to download 16S sequences from NCBI by parsing NCBI eUtils results and the NCBI taxonomy page, which only keeps sequences from type strains. In cases of multiple sequences for one type strain, it selects the sequence obtaining the best identity rate from the BLASTn alignment with our sequence. The script then separates 16S gene sequences in two groups: one containing the sequences of strains from the same genus (group A) and one containing the others (group B). It finally only keeps the 48 closest strains from group A and the closest three strains from group B. Different species are selected because they are the closest species of each five studied strains.

All the spectra were integrated into the URMITE database (<http://www.mediterranee-infection.com/article.php?laref=256&titre=urms-database>). We compared the proteomic profiles between our strains and their closest species.

### Phenotypic features {#sec1.1.2}

Optimal growth conditions of our strains were determined by testing five growth temperatures (20, 25, 30, 37 and 45°C) in an aerobic atmosphere with or without 5% CO~2~ and under anaerobic and microaerophilic conditions using the GENbag anaer and GENbag microaer systems, respectively (bioMerieux, Marcy l'Etoile, France). Phenotypic characteristics such as Gram staining, motility, sporulation, and catalase and oxidase activities were tested as previously described [@bib14]. Negative staining was done in order to observe cell morphology. Cells were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer for at least 1 hour at 4°C. A drop of cell suspension was deposited for approximately 5 minutes on glow-discharged formvar carbon film on 400 mesh nickel grids (FCF400-Ni; Electron Microscopy Sciences (EMS), Hatfield, PA, USA). The grids were dried on blotting paper, and the cells were negatively stained for 10 seconds with 1% ammonium molybdate solution in filtered water at room temperature. Electron micrographs were acquired with a Tecnai G20 Cryo (FEI Company, Limeil-Brévannes, France) transmission electron microscope operated at 200 keV.

Biochemical analysis of SD1, Marseille-P2825, Marseille-P2225, Marseille-P2818, Marseille-P3257 and Marseille-P3109 was carried out using API 50CH, API 20A and API ZYM strips according to manufacturer\'s instructions (bioMérieux). [Table 2](#tbl2){ref-type="table"} lists data of our six new species compared to published data of type strains of close species: *Actinomyces oricola* strain CIP 107639 [@bib21], *A. gerencseriae* strain CIP 105418 [@bib22], *A. naeslundii* strain CIP 103128 [@bib22], [@bib23], *A. timonensis* strain 7400942 [@bib24] and *A. massiliensis* strain 4401292 [@bib25].Table 2Comparison of phenotypic characteristicsTable 2CharacteristicABCDEFGHIJKOptimal temperature37°C37°C37°C37°C37°C37°C37°C37°C37°C37°C37°CAtmosphereAnaerobicAerobicAerobicAnaerobicAerobicAnaerobicAnaerobicAnaerobicAnaerobicAnaerobicAnaerobicpH range5.0--8.05.0--8.06.0--8.55.0--8.06.0--8.56.0--7.5NA5.7 - 6.6NANANAColony aspectSmooth and greyBright greySmooth and shinySmooth and white colourSmooth and greyTranslucent, beige micro coloniesPin point, breadcrumb like, white and nonhaemolyticCircular, peaked to pulvinate, lumpy, opaque and whiteNACircular, white, dry, embedded in the agar and pin pointCircular, white, shiny and pinpointCell shapeRod shapedRod shapedRod shapedRod shapedRod shapedRod shapedRod shapedRod shapedRod shapedRod shapedRod shapedCell size (μm)1.5--1.90.7--12.0--2.22.3--2.61.6--1.80.4--0.6NANANA1.0--3.20.5--1.7Cell diameter (μm)0.5--0.60.5--0.70.4--0.50.5--0.60.6--0.70.2--0.4NANANA0.3--0.50.35--0.74Gram stainPositivePositivePositivePositivePositivePositivePositivePositivePositivePositivePositiveSalt tolerance (g.L-1)\<10%\<10%5\<10%510--15%NANANANANAMotilityNoNoNoNoNoNoNoNoNoNANAEndospore formationNoNoNoNoNoNoNoNoNoNoNoMajor cellular fatty acid18:1n916:018:1n918:1n916:016:016:0NANANA18:1v9cProduction of:Alkaline phosphatase−−−−−−−−−−−Catalase−−−−−−−−−−−Oxidase−−−−−−NA−NA−−Nitrate reductase+−+−+−−++−+Urease−−++++−−−−−β-Galactosidase++++−−−++−+*N*-Acetyl-glucosamine+−+−++−−−−−Acid from:[l]{.smallcaps}-Arabinose−−−+−+−−−−−Ribose−−++++−−−w/+−/wMannose−+++++−−/++w/+−/wMannitol−−−−−+−−−+−[d]{.smallcaps}-Saccharose++++++NANANANA[d]{.smallcaps}-Glucose+−++++−−/++++[d]{.smallcaps}-Fructose+−++++−−+++[d]{.smallcaps}-Maltose+−+−++−−/++++[d]{.smallcaps}-Lactose++−+++−+−++HabitatHuman stomachHuman gutHuman lungHuman duodenumHuman lungHuman bladderHuman dental abscessHuman parotid abscessHuman sinusHuman clinical osteo-articularHuman blood[^2][^3]

Cellular fatty acid methyl ester (FAME) analysis was performed by gas chromatography/mass spectrometry (GC/MS). FAMEs were prepared as described by Sasser [@bib26]. GC/MS analyses were carried out as previously described [@bib27]. Briefly, FAMEs were separated using an Elite 5-MS column and monitored by mass spectrometry (Clarus 500-SQ 8 S; PerkinElmer, Courtaboeuf, France). A spectral database search was performed using MS Search 2.0 operated with the Standard Reference Database 1A (National Institute of Standards and Technology, Gaithersburg, MD, USA) and the FAME mass spectral database (Wiley, Chichester, UK). Antibiotic susceptibility was tested using the disc diffusion method [@bib28] and according to European Committee on Antimicrobial Susceptibility Testing 2015 recommendations.

### Genome description and comparison {#sec1.1.3}

Genomic DNA (gDNA) of *Actinomyces urinae, Actinomyces mediterranea, Actinomyces oralis* and *Actinomyces marseillensis* were first extracted by a mechanical treatment by acid-washed glass beads (G4649-500g; Sigma, St Louis, MO, USA) using a FastPrep BIO 101 instrument (Qbiogene, Strasbourg, France) at maximum speed (6.5) for 3 × 30 seconds. Then, for all the *Actinomyces* strains, successive pretreatments by a lysozyme incubation at 37°C for 2 hours (3 hours for *Actinomyces oralis*) were done, followed by proteinase K for 3 hours for *Actinomyces ihuae* only. gDNA was then extracted on the EZ1 biorobot (Qiagen) with the EZ1 DNA tissues kit. The elution volume was 50 μL. gDNA was quantified by a Qubit assay with a high-sensitivity kit (Life Technologies, Carlsbad, CA, USA) ([Supplementary Table S1](#appsec1){ref-type="sec"}).

The genome\'s assembly was performed with a pipeline that enabled us to create an assembly with different software (Velvet [@bib29], Spades [@bib30] and Soap Denovo [@bib31]) on untrimmed data. gDNA was sequenced by MiSeq Technology (Illumina, San Diego, CA, USA) with the mate-pair strategy for all the *Actinomyces* strains, and paired end for *Actinomyces urinae, Actinomyces mediterrane* and *Actinomyces oralis.* The gDNA was barcoded in order to be mixed with 11 other projects with the Nextera Mate Pair sample prep kit (Illumina).

The mate-pair library was prepared with 1.5 μg of gDNA using the Nextera mate-pair Illumina guide. The gDNA sample was simultaneously fragmented and tagged with a mate-pair junction adapter. The pattern of the fragmentation was validated on an Agilent 2100 BioAnalyzer (Agilent Technologies, Santa Clara, CA, USA) with a DNA 7500 labchip. The DNA fragments ranged in size from 1 to 11 kb (with an optimal size at 2.458, 2.458, 6.284, 5.830, 9.683 and 6.518kb for *A. urinae, A. mediterranea, A. oralis, A. ihuae, A. bouchedurhonensis* and *A. marseillensis,* respectively). No size selection was performed, and 600 ng (for *A. marseillensis and A. ihuae*), 284.7 ng (for *A. bouchedurhonensis*), 96.1 ng (for *Actinomyces urinae*), 112 ng (for *A. mediterranea*) and 250.7 ng (for *Actinomyces oralis*) of tagmented fragments were circularized. The circularized DNA was mechanically sheared to small fragments, with an optimum at 1163, 1041, 406, 736, 1033 and 949 bp for *A. urinae, A. mediterranea, A. oralis, A. ihuae, A. bouchedurhonensis* and *A. marseillensis,* respectively, on the Covaris device S2 in T6 tubes (microtubes for *A. oralis* and *A. marseillensis*) (Covaris, Woburn, MA, USA). The library profile was visualized on a High Sensitivity Bioanalyzer LabChip (Agilent Technologies), and the final concentration library was measured ([Supplementary Table S1](#appsec1){ref-type="sec"}). The libraries were normalized at 2 nM (4 nM for *A. ihuae*) and pooled. After a denaturation step and dilution at 15 pM, the pool of libraries was loaded onto the reagent cartridge and then onto the instrument along with the flow cell. Automated cluster generation and a sequencing run were performed in a single 39-hour run in a 2 × 251 bp read length (2 × 250 bp read length for *A. oralis, A. marseillensis* and *A. marseillensis*). The paired reads were finally trimmed and assembled. For each assembly performed, GapCloser [@bib31] was used to reduce gaps. Complementary information is provided in [Supplementary Table S1](#appsec1){ref-type="sec"}.

To prepare the paired end library, dilution was performed to require 1 ng of each genome as input. The tagmentation step fragmented and tagged the DNA. Then limited-cycle PCR amplification (12 cycles) completed the tag adapters and introduced dual-index barcodes. After purification on AMPure XP beads (Beckman Coulter, Brea, CA, USA), the libraries were then normalized on specific beads according to the Nextera XT protocol (Illumina). Normalized libraries were pooled for sequencing on the MiSeq device. Automated cluster generation and paired-end sequencing with dual index reads were performed in a single 39-hour run in 2 × 250 bp read length. Complementary information is available in [Supplementary Table S1](#appsec1){ref-type="sec"}.

Open reading frames (ORFs) were predicted using Prodigal [@bib32] with default parameters, but the predicted ORFs were excluded if they spanned a sequencing gap region. The predicted bacterial protein sequences were searched against the GenBank [@bib33] and the Clusters of Orthologous Groups database (COGs) using BLASTP (*E* value 1e-03, coverage 0.7 and identity percentage of 30%). If no hit was found, it was searched against the NR database using BLASTP with an *E* value of 1e-03, coverage of 0.7 and an identity percentage of 30%, and if the sequence length was smaller than 80 aa, we used an *E* value of 1e-05. The tRNAScanSE tool [@bib34] was used to find tRNA genes, while ribosomal RNAs were found using RNAmmer [@bib35]. Lipoprotein signal peptides and the number of transmembrane helices were predicted using Phobius [@bib36]. Mobile genetic elements were predicted using PHAST [@bib37] and RAST [@bib38]. ORFans were identified if all the BLASTP performed did not give positive results (*E* value smaller than 1e-03 for ORFs with sequence size larger than 80 aa or *E* value smaller than 1e-05 for ORFs with sequence length smaller than 80 aa). Such parameter thresholds have already been used in previous studies to define ORFans. Artemis [@bib39] and DNA Plotter [@bib40] were used for data management and the visualization of genomic features, respectively. The Mauve alignment tool (version 2.3.1) was used for multiple genomic sequence alignment [@bib41]. PFAM-A conserved domains were searched on each protein with the HMMscan of the HMMER3 suite [@bib42]. PKS and NRPS were searched against the ClusterMine360 [@bib43] database. Resistome was analysed by using the ARG-ANNOT database [@bib44]. The closest species for genomic comparison were identified in the 16S RNA tree using Phylopattern software [@bib45]. For each selected genome, the complete genome sequence, proteome genome sequence and ORFeome genome sequence were retrieved from the FTP of NCBI.

An annotation of the entire proteome was performed to define the distribution of functional classes of predicted genes according to the COGs of proteins (using the same method as for the genome annotation). Annotation and comparison processes were performed in the multiagent software system DAGOBAH [@bib46], which includes Figenix [@bib47] libraries that provide pipeline analysis. To evaluate the genomic similarity between studied genomes, we determined two parameters, digital DNA-DNA hybridization (dDDH), which exhibits a high correlation with DNA-DNA hybridization (DDH) [@bib20], [@bib48], and average genomic identity of orthologous gene sequences (AGIOS), which was designed to be independent from DDH. The AGIOS score is the mean value of nucleotide similarity between all couples of orthologous proteins between the two studied genomes [@bib49].

Results {#sec2}
=======

Strain identification and phylogenetic analysis {#sec2.1}
-----------------------------------------------

A phylogenetic tree of our strains is provided in [Fig. 2](#fig2){ref-type="fig"}. Strain SD1 (accession no. LN866997) exhibited a 98.6% 16S rRNA gene sequence identity with *Actinomyces radingae* strain APL1 (accession no. NR_026169), the closest species with a validly published name. We therefore suggested that our strain is a representative strain of a new species within the genus *Actinomyces,* for which we suggest the name *Actinomyces ihuae* strain SD1 (= CSUR P2006 = DSM 100538). Strain Marseille-P2825 (accession no. LT576385) revealed a 98.33% sequence similarity with the 16S rRNA of *Actinomyces odontolyticus* strain JCM 14871 (accession no. [AJ234040](ncbi-n:AJ234040){#intref0025}), the closest species with a validly published name. We therefore suggested that our strain is a representative strain of a new species within the genus *Actinomyces,* for which we suggest the name *Actinomyces bouchesdurhonensis* strain Marseille-P2825 (= CSUR P2825 = DSM 103075). Strain Marseille-P2225 (accession no. LN870295) revealed an exhibited 98.45% sequence identity with *Actinomyces europaeus* strain CCUG 32789A (accession no. NR_026363), the closest species with a validly published name. We therefore suggested that our strain is a representative strain of a new species within the genus *Actinomyces,* for which we suggest the name *Actinomyces urinae* strain Marseille-P2225 (= CSUR P2225 = DSM 100700). Strain Marseille-P2818 (accession no. LT576400) exhibited a 98.1% 16S rRNA gene sequence identity with *Actinomyces odontolyticus* strain JCM 14871 (accession no. [AJ234040](ncbi-n:AJ234040){#intref0030}), the closest species with a validly published name. We therefore suggested that our strain is a representative strain of a new species within the genus *Actinomyces,* for which we suggest the name *Actinomyces marseillensis* strain Marseille-P2818 (= CSUR P2818 = CCUG 71898). Furthermore, *Actinomyces bouchesdurhonensis* strain Marseille-P2825 and *Actinomyces marseillensis* strain Marseille-P2818 showed only 97.55% of 16S gene sequence identity, indicating that there are two distinct species of *Actinomyces odontolyticus.* Strain Marseille-P3257 (accession no. LT598588) exhibited 93.94% 16S rRNA gene sequence identity with *Actinomyces hyovaginalis* strain BM 1192/5 (accession no. [X69616](ncbi-n:X69616){#intref0035}), the closest species with a validly published name. We therefore suggested that our strain is a representative strain of a new species within the genus *Actinomyces,* for which we suggest the name *Actinomyces mediterranea* strain Marseille-P3257 (= CSUR P3257 = CCUG 70143). Strain Marseille-P3109 (accession no. LT627670) revealed a 98.5% of sequence similarity with the 16S rRNA of *Actinomyces naeslundii* strain JCM 8349 (accession no. NR_113326), the closest species with a validly published name. We therefore suggested that our strain is a representative strain of a new species within the genus *Actinomyces,* for which we suggest the name *Actinomyces oralis* strain Marseille-P3109 (= CSUR P3109 = DSM 103942).Fig. 2Phylogenetic tree highlighting position of *Actinomyces ihuae* strain SD1, *Actinomyces bouchesdurhonensis* strain Marseille-P2825, *Actinomyces urinae* strain Marseille-P2225, *Actinomyces marseillensis* strain Marseille-P2818, *Actinomyces mediterranea* strain Marseille-P3257 and *Actinomyces oralis* strain Marseille-P3109 relative to other type strains within *Actinomyces* genus. Strains and their corresponding GenBank accession numbers for 16S rRNA genes sequences are indicated in brackets. Sequences were aligned using CLUSTALW (<http://www.clustal.org/clustal2/>), and phylogenetic inferences were obtained using maximum-likelihood method within MEGA 6 (<http://www.megasoftware.net/mega.php>). Numbers at nodes are percentages of bootstrap values obtained by repeating analysis 1000 times to generate majority consensus tree. *Actinobaculum urinale* (NR 028978.1) was used as outgroup. Scale bar = 1% nucleotide sequence divergence.Fig. 2

The analysis of the gel view shows that all the profiles of our studied strains have similar general characteristics with the other *Actinomyces* species used for the comparison ([Fig. 3](#fig3){ref-type="fig"}). Furthermore, the outsider species *Actinobaculum urinale* strain DSM 15805 profile shows several unique differences.Fig. 3Reference mass spectra from *Actinomyces ihuae* strain SD1, *Actinomyces bouchesdurhonensis* strain Marseille-P2825, *Actinomyces urinae* strain Marseille-P2225, *Actinomyces marseillensis* strain Marseille-P2818, *Actinomyces mediterranea* strain Marseille-P3257 and *Actinomyces oralis* strain Marseille-P3109. Spectra from 12 individual colonies were compared and each reference spectrum generated (A). Gel view comparing *Actinomyces ihuae* strain SD1, *Actinomyces bouchesdurhonensis* strain Marseille-P2825, *Actinomyces urinae* strain Marseille-P2225, *Actinomyces marseillensis* strain Marseille-P2818, *Actinomyces mediterranea* strain Marseille-P3257 and *Actinomyces oralis* strain Marseille-P3109 to other species within genus *Actinomyces*. Gel view displays raw spectra of loaded spectrum files arranged in pseudo-gel--like look; *x*-axis indicates *m/z* value and left *y*-axis running spectrum number originating from subsequent spectra loading. Peak intensity expressed by greyscale scheme code. Colour bar and right *y*-axis indicate relation between colour peak, with peak intensity in arbitrary units. Displayed species are indicated at left (B).Fig. 3

Phenotypic features {#sec2.2}
-------------------

The main phenotypic results of each studied strains are presented in [Table 2](#tbl2){ref-type="table"}. Results show that these six new species are all Gram positive and rod shaped. These observations have been permitted by electronic microscopy ([Fig. 4](#fig4){ref-type="fig"}), which reveals similar morphologies characteristic of the *Actinomyces* genus.Fig. 4Gram staining and electron micrographs, respectively, of *Actinomyces oralis* strain Marseille-P3109 (A, B), *Actinomyces ihuae* strain SD1 (C, D), *Actinomyces bouchesdurhonensis* strain Marseille-P2825 (E, F), *Actinomyces urinae* strain Marseille-P2225 (G, H), *Actinomyces marseillensis* strain Marseille-P2818 (I, J) and *Actinomyces mediterranea* strain Marseille-P3257 (K, L).Fig. 4

The cellular fatty acid composition of our strains is provided in [Table 3](#tbl3){ref-type="table"}, and the antibiotic analyses are presented in [Table 4](#tbl4){ref-type="table"}. As [Table 3](#tbl3){ref-type="table"} indicates, 9-octadecenoic acid and hexadecanoic acid were the two most abundant cellular fatty acid of all the bacteria. 9-Octadecenoic acid was the most abundant for the strains Marseille-P2825, Marseille-P2818 and Marseille-P3257; and hexadecanoic acid was the second most abundant. Hexadecanoic acid was the most abundant for the strains Marseille-P2225, SD1 and Marseille-P3109; and 9-octadecenoic acid was the second most abundant. [Table 4](#tbl4){ref-type="table"} shows the results of antibiotic susceptibility tests. The strains were all susceptible to amoxicillin 25 μg, rifampicin 30 μg and gentamicin 500 μg and were resistant to colistin 50 μg and metronidazole 4 μg. These results support the notion that these strains are all members of the same *Actinomyces* genus.Table 3Cellular fatty acid composition (in %[a](#tbl3fna){ref-type="table-fn"})Table 3Fatty acidIUPAC nameABCDEF12:0Dodecanoic acid1.0 ± 0.2TRTRTR1.6 ± 0.3TR14:0Tetradecanoic acid8.4 ± 1.51.2 ± 0.13.8 ± 0.32.3 ± 0.33.9 ± 0.21.9 ± 0.116:0Hexadecanoic acid30.1 ± 1.932.3 ± 0.127.9 ± 3.532.2 ± 0.555.0 ± 0.244.9 ± 0.316:1n79-Hexadecenoic acidTRTRNoTR2.1 ± 0.2No17:0Heptadecanoic acidTR1.2 ± 0.1TRTRTRTR18:0Octadecanoic acid14.3 ± 2.518.0 ± 1.213.2 ± 0.620.1 ± 0.33.7 ± 0.518.1 ± 0.818:1n513-Octadecenoic acidNoNoNoTRNo2.5 ± 0.118:1n612-Octadecenoic acidNoNo1.1 ± 0.1NoNoNo18:1n711-Octadecenoic acid3.0 ± 0.23.1 ± 0.31.4 ± 0.21.4 ± 0.1No1.5 ± 0.218:1n99-Octadecenoic acid32.4 ± 1.723.8 ± 0.644.9 ± 3.835.1 ± 1.031.4 ± 0.221.4 ± 0.818:2n69,12-Octadecadienoic acid8.7 ± 0.416.8 ± 0.35.8 ± 1.06.8 ± 0.12.1 ± 0.37.8 ± 0.3[^4][^5][^6]Table 4Antibiotic resistance testsTable 4CharacteristicABCDEFIMCStatusIMCStatusIMCStatusIMCStatusIMCStatusIMCStatusGentamicin 15 μg3R9R11.1I7R24.6S0RGentamicin 500 μg16I25S30.6S35S34.3S21.5SAmoxicillin/clavulanic acid 30 μg20I26S30.0S30S41.9S9.8RCeftriaxone 30 μg21R20R14.4R\>30S40.4S19.1RColistin 50 μg0R0R0R0R0R0RPenicillin G 10 IU21I27I20.2I28I33.9S16.1RImipenem 10 μg26S30S31.1S\>30S22.6I22.4ITrimethoprim/sulfamethoxazole 25 μg6R5R30.7S11I0R0RClindamycin 15 μg30S24.1S23.9S25S7.4R10.9RMetronidazole 4 μg6R10R19.8R5R6.5R0RTobramycin 10 μg7R10.9R23.7S12R0R0RRifampicin 30 μg25S28S19.4S\>30S40.0S14.4IFosfomycin 50 μg7R12R6.5R\>30S13.5R9.4RAmoxicillin 25 μg22I29.4S31.5S\>30S36.3S27.0SVancomycin 30 μg13R20S27.6S22S32.4S17.2SDoxycycline 30 IU3R29.2S28.3S\>30S8.9R27.2SErythromycin 15 IU24S10R30.6S\>30S19.4I9.4R[^7][^8]

Genome description and comparison {#sec2.3}
---------------------------------

Maps of genomes of our different strains are presented in [Supplementary Fig. S1](#appsec1){ref-type="sec"}. The properties and statistics of the genomes are summarized in [Table 5](#tbl5){ref-type="table"}, and the distribution of predicted genes of our strains according to COGs categories are shown in [Table 6](#tbl6){ref-type="table"}. We can observe that for all the 25 general COGs functional categories, values of our six new *Actinomyces* species are in the same range. Genomic characteristics of our strains are compared to those of closely related species with an available genome in [Table 7](#tbl7){ref-type="table"}. Although the genome *A. urinae* is smaller than the other species, it has the same GC percentage range, between 49.60% and 72.58%, as the other characterized genomes of known *Actinomyces* species [@bib50], [@bib51]. Furthermore, dDDH values ([Table 8](#tbl8){ref-type="table"}) are less than 70% and confirm that all the studied species are distinct species [@bib20], [@bib48]. These results are supported by AGIOS values ([Supplementary Table S2](#appsec1){ref-type="sec"}), which demonstrated that comparison between our strains and other species within *Actinomyces* genus resulted in a similar range of values compared to the comparison between the same species except our strains, thus confirming their new species status.Table 5Nucleotide content and gene counts levels of genomeTable 5CharacteristicABCDEFScaffolds; contigs31; 1145; 52; 184; 48; 83; 4**Value% of total**[a](#tbl5fna){ref-type="table-fn"}**Value% of total**[a](#tbl5fna){ref-type="table-fn"}**Value% of total**[a](#tbl5fna){ref-type="table-fn"}**Value% of total**[a](#tbl5fna){ref-type="table-fn"}**Value% of total**[a](#tbl5fna){ref-type="table-fn"}**Value% of total**[a](#tbl5fna){ref-type="table-fn"}Size (bp)2 304 249100.02 458 350100.02 007 553100.02 395 621100.03 149 2331001 946 897100.0G+C content (%)1 436 33863.31 447 60158.91 131 73857.11 528 16263.82 154 17768.41 092 83056.1Coding region (bp)1 612 52270.02 240 37691.11692100.02 151 62489.82 750 32187.31 787 92091.8Total genes1821100.02.200100.01754100.02133100.02639100.01756100.0Protein-coding genes1766100.02135100.01692100.02081100.02579100.01701100.0RNA genes553.0653.0623.5522.4602.3553.1Proteins with function prediction125771.2153371.8127975.6157175.5201378.1125773.9Proteins assigned to COGs101657.5132462.0109164.5131263.0161562.6116668.5Proteins with peptide signals18110.22059.620312.023911.528711.117910.5No. of proteins associated with ORFan895.01426.7332.01004.8552.1372.2Genes associated with PKS or NRPS20.130.140.280.4120.540.2No. of antibiotic resistance genes00.010.000.000.000.000.0No. of genes associated with Pfam-A domains151983.0193688.0154988.01.8988.0238190.0158390.0[^9][^10][^11]Table 6Number of genes associated with 25 general COGs functional categoriesTable 6CodeDescriptionABCDEFValue% of total[a](#tbl6fna){ref-type="table-fn"}Value% of total[a](#tbl6fna){ref-type="table-fn"}Value% of total[a](#tbl6fna){ref-type="table-fn"}Value% of total[a](#tbl6fna){ref-type="table-fn"}Value% of total[a](#tbl6fna){ref-type="table-fn"}Value% of total[a](#tbl6fna){ref-type="table-fn"}JTranslation1458.211567.311639.631667.981656.401589.29ARNA processing and modification10.0710.0410.0610.0510.0410.06KTranscription653.69914.26704.14984.711455.62764.47LReplication, recombination and repair482.72713.33643.78683.27722.79653.82BChromatin structure and dynamics00.000.000.000.000.000.0DCell cycle control, mitosis and meiosis191.08221.03181.06190.91200.78211.23YNuclear structure00.000.000.000.000.000.0VDefense mechanisms372.10411.92362.13432.07682.64342.0TSignal transduction mechanisms321.81411.92311.83422.02672.60321.88MCell wall/membrane biogenesis553.11592.76492.90723.46883.41603.53NCell motility60.3460.2860.3580.3880.3170.41ZCytoskeleton00.000.000.000.010.0400.0WExtracellular structures30.1740.1910.0640.1940.1640.24UIntracellular trafficking and secretion150.85170.80171.00160.77190.74191.12OPosttranslational modification, protein turnover, chaperones563.17612.86593.49643.08642.48603.53XMobilome: prophages, transposons512.89210.9820.12190.91271.05130.77CEnergy production and conversion633.57813.79734.31914.37923.57814.77GCarbohydrate transport and metabolism895.0421810.211186.971868.942057.951518.88EAmino acid transport and metabolism985.551265.901136.681316.301696.551116.53FNucleotide transport and metabolism502.83733.42513.01673.22712.75673.94HCoenzyme transport and metabolism623.51743.47593.49633.031023.96663.89ILipid transport and metabolism341.93381.78513.01492.35652.52372.18PInorganic ion transport and metabolism512.89723.37673.96602.88913.53704.12QSecondary metabolites biosynthesis, transport and catabolism160.91170.80140.83180.86351.36191.12RGeneral function prediction only744.19994.64844.961125.381495.78774.53SFunction unknown533.00673.14543.19512.45793.06533.12---Not in COGs75042.4781138.060135.5276936.9596437.3953531.45[^12][^13][^14]Table 7Genome comparison of closely related species.Table 7OrganismStrainINSDCSize (Mb)G+C%Total genes*Actinotignum massiliense*FC3CYUL000000002.06760.171771*Actinobaculum suis*C1-22-1MASX000000002.2357.751611*Actinomyces bouchedurhonensis*Marseille-P2825FQSA000000002.363.281766*Actinomyces cardiffensis*F0333AQHZ000000002.1961.491983*Actinomyces coleocanis*DSM 15436ACFG000000001.7249.601546*Actinomyces europaeus*ACS-120-V-Col10bAGWN000000001.91156.651670*Actinomyces georgiae*DSM 6843AUBM000000002.569.872103*Actinomyces graevenitzii*C83ACRN000000002.2157.801853*Actinomyces ihuae*SD1CZPX000000002.4558.892135*Actinomyces israelii*DSM 43320JONS000000004.0371.443387*Actinomyces johnsonii*F0542AWSE000000003.3367.453324*Actinomyces marseillensis*Marseille-P2818FTLP000000002.0157.091692*Actinomyces mediterranea*Marseille-P3257FTPB000000002.463.792081*Actinomyces meyeri*W712CP0120722.0565.511667*Actinomyces naeslundii*Howell 279ALJK000000003.1167.852930*Actinomyces neuii* subsp. *neuii*DSM 8576ATUW000000002.2756.182013*Actinomyces odontolyticus*F0309ACYT000000002.4365.252372*Actinomyces oralis*Marseille-P3109OOHN000000003.1568.402579*Actinomyces oris*K20BABV000000002.8767.803006*Actinomyces radicidentis*CCUG 36733CP0142283.0572.582342*Actinomyces slackii*ATCC 49928AUAK000000003.1770.142611*Actinomyces suimastitidis*DSM 15538AUBF000000002.2956.431943*Actinomyces turicensis*ACS 279 V Col4AGWQ000000001.9557.181717*Actinomyces urinae*Marseille-P2225FPKP010000001.9556.131701*Actinomyces urogenitalis*DORA 12AZLV000000002.668.663034*Actinomyces viscosus*C505ACRE000000003.1368.602587*Isoptericola dokdonensis*DS-3CP0142093.8373.813403*Isoptericola variabilis*JZ7LWGM000000003.4874.583529*Mobiluncus curtisii* subsp. *curtisii*ATCC 43063CP0019922.1555.411909*Mobiluncus mulieris*28-1ADBR000000002.4555.072321*Varibaculum cambriense*DORA 20AZMI000000002.2852.762025[^15]Table 8dDDH comparison[a](#tbl8fna){ref-type="table-fn"}Table 8ABCDEFGHIJKA100% ± 00B20.80% ± 2.35100% ± 00C22.30% ± 2.3521.70% ± 2.35100% ± 00D21.40% ± 2.3521.30% ± 2.3522.90% ± 2.40100% ± 00E20.70% ± 2.3022.10% ± 2.3522.00% ± 2.3519.80% ± 2.30100% ± 00F21.40% ± 2.3527.50% ± 2.4026.20% ± 2.4018.10% ± 2.2523.10% ± 2.40100% ± 00G21.30% ± 2.3520.20% ± 2.3021.60% ± 2.3523.70% ± 2.4019.80% ± 2.3025.50% ± 2.40100% ± 00H21.20% ± 2.3524.90% ± 2.4023.70% ± 2.4019.50% ± 2.3025.10% ± 2.4030.90% ± 2.4522.70% ± 2.35100% ± 00I20.40% ± 2.2020.70% ± 2.3521.90% ± 2.3519.60% ± 2.334.80% ± 2.4521.80% ± 2.3519.00% ± 2.3022.30% ± 2.35100% ± 00J20.60% ± 2.3522.10% ± 2.3522.40% ± 2.3519.90% ± 2.3535.00% ± 2.5024.50% ± 2.4019.90% ± 2.3025.00% ± 2.4023.50% ± 2.40100% ± 00K25.90% ± 2.4019.70% ± 2.3022.60% ± 2.4020.90% ± 2.3520.10% ± 2.3020.10% ± 2.3021.50% ± 2.3520.40% ± 2.3520.20% ± 2.3021.40% ± 2.35100% ± 00[^16][^17][^18]

Conclusion {#sec3}
==========

In this study, we used the polyphasic approach developed in our laboratory to describe six new species of the *Actinomyces* genus. This concept is based on genome sequences, MALDI-TOF MS identification and main phenotypic characteristics of the studied new species. As previously observed, the presented strains, which have been isolated from diverse origin, possess close morphologic properties. Their cellular fatty acid composition and their profile of resistance to antibiotics support that these five strains belong to the same genus. Their 16S rRNA gene sequencing, supported by genome analysis compared to other characterized strains of the *Actinomyces* genus, indicated that *Actinomyces ihuae* strain SD1, *Actinomyces bouchesdurhonensis* strain Marseille-P2825, *Actinomyces urinae* strain Marseille-P2225, *Actinomyces marseillensis* strain Marseille-P2818, *Actinomyces mediterranea* strain Marseille-P3257 and *Actinomyces oralis* strain Marseille-P3109 are all members of the *Actinomyces* genus.

Description of *'Actinomyces ihuae'* sp. nov. {#sec3.1}
---------------------------------------------

Cells are Gram positive and rod shaped, with a length of 0.7 to 1 μm and a width of 0.5 to 0.7 μm. This strain exhibited no catalase or oxidase activity. *'Actinomyces ihuae'* is nonmotile and non--spore forming. Colonies are bright grey, with a diameter of 1 to 2 mm. Optimum growth occurs at 37°C in an aerobic atmosphere on Colombia agar enriched with 5% sheep\'s blood after 24 hours\' growth. Strain SD1 was susceptible to gentamicin (500 μg/mL), amoxicillin/clavulanic acid (30 μg/mL), clindamycin (15 μg/mL), imipenem (10 μg/mL), rifampicin (30 μg/mL), amoxicillin (25 μg/mL), doxycycline (30 IU) and vancomycin (30 μg/mL). The major fatty acid is hexadecanoic acid. The genome of strain SD1^T^ is 2 458 350 bp long with 58.89% G+C content. The 16S rRNA gene and genome sequences are available in the European Molecular Biology Laboratory (EMBL)-EBI (European Bioinformatics Institute) database under accession numbers LN866997 and CZPX00000000, respectively.

We propose the new species *'Actinomyces ihuae'* (i.hu.ae, N.L. gen. adj., *ihuae,* which is based on the acronym IHU, for Institut Hospitalo-Universitaire in Marseille, France, where the strain was isolated), isolated from stool. Strain SD1^T^ is the type strain of the new species *'Actinomyces ihuae'* (= CSUR P2006 = DSM 100538).

Description of *'Actinomyces bouchesdurhonensis'* sp. nov. {#sec3.2}
----------------------------------------------------------

Cells are Gram-positive bacilli with a length of 1.5 to 1.9 μm and a width of 0.5 to 0.6 μm. This strain did not exhibit catalase and oxidase activity. *Actinomyces bouchesdurhonensis* is nonmotile and non--spore forming. Colonies are smooth and grey with a diameter of 0.6 to 1.5 mm. Optimum growth occurs at 37°C in an anaerobic atmosphere on Colombia agar enriched with 5% sheep\'s blood after 24 hours\' growth.

Marseille-P2825 was susceptible to rifampicin (30 μg/mL), clindamycin (15 μg/mL), imipenem (10 μg/mL) and erythromycin (15 IU). The major fatty acid is 9-octadecenoic acid.

The genome of strain Marseille-P2825 is 2 304 249 bp long with 63.28% of G+C content. The 16S rRNA gene and genome sequences are available in the EMBL-EBI database under accession numbers LT576385 and FQSA01000000, respectively.

We propose the new species *'Actinomyces bouchesdurhonensis'* sp. nov. (bou.ches.du.rho.nen\'sis, N.L. neut. adj. *bouchesdurhonensis,* pertaining to Boûches du Rhône, the name of the French territory where the strain was isolated) was isolated from a stomach wash. Strain Marseille-P2825^T^ is the type strain of the new species *'Actinomyces bouchesdurhonensis'* (= CSUR P2825 = DSM 103075).

Description of *'Actinomyces urinae'* sp. nov. {#sec3.3}
----------------------------------------------

Marseille-P2225 is a Gram-positive rod-shape with a length of 400 to 600 nm and width of 200 to 400 nm. This strain no catalase and no oxidase activity. *'Actinomyces urinae'* is nonmotile and non--spore forming. Colonies are translucent, beige microcolonies, with a diameter of 100 μm. Optimum growth occurs at 37°C in an anaerobic atmosphere on Colombia agar enriched with 5% sheep\'s blood after 48 hours\' growth.

Strain Marseille-P2225 was susceptible to gentamicin (500 μg/mL), amoxicillin (25 μg/mL), doxycycline (30 IU) and vancomycin (30 μg/mL). The major fatty acid is hexadecanoic acid.

The genome of strain Marseille-P2225 is 1 946 897 bp long with 56.13% of G+C content. The 16S rRNA gene and genome sequences are available in the EMBL-EBI database under accession numbers LN870295 and FPKP01000000, respectively.

We propose the creation of the new species *'Actinomyces urinae'* sp. nov. (u.ri.na\'e, N.L. gen. fem. *urinae,* 'of urine'), which was isolated from urine. Strain Marseille-P2225^T^ is the type strain of the new species *'Actinomyces urinae'* (= CSUR P2225 = DSM 100700).

Description of *'Actinomyces marseillensis'* sp. nov. {#sec3.4}
-----------------------------------------------------

Cells are Gram positive and rod shaped, with a length of 2.0 to 2.2 μm and a width of 0.4 to 0.5 μm. This strain exhibited no catalase or oxidase activity. *'Actinomyces marseillensis'* is nonmotile and non--spore forming. Colonies are smooth and shiny with a diameter of 0.5 to 1.5 mm. Optimum growth occurs at 37°C in an aerobic atmosphere on Colombia agar enriched with 5% sheep\'s blood after 24 hours\' growth.

Strain Marseille-P2818 was susceptible to gentamicin (500 μg/mL), amoxicillin/clavulanic acid (30 μg/mL), amoxicillin (25 μg/mL), tobramycin (30 μg/mL), clindamycin (15 μg/mL), imipenem (10 μg/mL), rifampicin (30 μg/mL), doxycycline (30 IU) erythromycin (15 IU) and vancomycin (30 μg/mL). The major fatty acid is 9-octadecenoic acid.

The genome of strain Marseille-P2818 is 2 007 553 bp long with 57.09% of G+C content. The 16S rRNA gene and genome sequences are available in the EMBL-EBI database under accession numbers LT576400 and FTLP00000000, respectively.

*'Actinomyces marseillensis'* sp. nov. is proposed as new species (mar.sei.ll.en\'sis, L. gen. neut. adj., from *marseillensis,* pertaining to Marseille, where the strain was isolated). It was isolated from the sputum. Strain Marseille-P2818^T^ is the type strain of the new species *'Actinomyces marseillensis'* (= CSUR P2818 = CCUG 71898).

Description of *'Actinomyces mediterranea'* sp. nov. {#sec3.5}
----------------------------------------------------

Marseille-P3257 cells are Gram-positive bacilli with a length of 2.3 to 2.6 μm and a width of 0.53 to 0.61 μm. This strain did not exhibit catalase and oxidase activity. *'Actinomyces mediterranea'* is nonmotile and non--spore forming. Colonies are smooth and white in colour, with a diameter of 0.4 to 1.1 mm. Optimum growth occurs at 37°C in an anaerobic atmosphere on Colombia agar enriched with 5% sheep\'s blood after 24 hours\' growth. Strain Marseille-P3257 was susceptible to rifampicin (30 μg/mL), fosfomycin (50 μg/mL), doxycycline (30 IU), erythromycin (15 IU), gentamicin (500 μg/mL), amoxicillin/clavulanic acid (30 μg/mL), ceftriaxone (30 μg/mL), amoxicillin (25 μg/mL), clindamycin (15 μg/mL), imipenem (10 μg/mL) and vancomycin (30 μg/mL). The major fatty acid is 9-octadecenoic acid. The genome of strain Marseille-P3257 is 2 395 621 bp long with 63.79% GC content. The 16S rRNA gene and genome sequences are available in the EMBL-EBI database under accession numbers LT598588 and FTPB00000000, respectively.

We propose the new species *Actinomyces mediterranea* sp. nov. (me.di.ter.ra.ne.a, L. fem. adj. *mediterranea,* the Latin name of the Mediterranean Sea bordering Marseille, where the strain was isolated), which was isolated from the duodenum wash. Strain Marseille-P3257^T^ is the type strain of the new species *'Actinomyces mediterranea'* (= CSUR 3257 = CCUG 70143).

Description of *'Actinomyces oralis'* sp. nov. {#sec3.6}
----------------------------------------------

Cells are Gram positive and rod shaped, with a length of 1.6 to 1.8 μm and a width of 0.6 to 0.7 μm. This strain no exhibited catalase or oxidase activity. *'Actinomyces oralis'* is nonmotile and non--spore forming. Colonies are smooth and grey, with a diameter of 0.3 to 1.2 mm. Optimum growth occurs at 37°C in an aerobic atmosphere on Colombia agar enriched with 5% sheep\'s blood after 24 hours\' growth. Strain Marseille-P3109 was susceptible to rifampicin (30 μg/mL), gentamicin (15 μg/mL), gentamicin (500 μg/mL), amoxicillin/clavulanic acid (30 μg/mL), ceftriaxone (30 μg/mL), amoxicillin (25 μg/mL), penicillin G (10 IU) and vancomycin (30 μg/mL). The major fatty acid is hexadecanoic acid. The genome of strain Marseille-P3109 is 3 149 233 bp long with 68.40% of G+C content. The 16S rRNA gene and genome sequences are available in the EMBL-EBI database under accession numbers LT627670 and OOHN00000000, respectively.

We propose the creation of the new species *'Actinomyces oralis'* sp. nov. (o.ra\'lis, N.L. neut. adj. *oralis,* 'from the mouth,' from which the strain was isolated), which was isolated from human sputum. Strain Marseille-P3109^T^ is the type strain of the new species *'Actinomyces oralis'* (= CSUR P3109 = DSM 103942).
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[^1]: A, *Actinomyces bouchesdurhonensis* strain Marseille-P2825; B, *A. ihuae* strain SD1^T^; C, *A. marseillensis* strain Marseille-P2818; D, *A. mediterranea* strain Marseille-P3257; E, *A. oralis* strain Marseille-P3109; F, *A. urinae* strain Marseille-P2225.

[^2]: A, *Actinomyces bouchesdurhonensis* strain Marseille-P2825; B, *A. ihuae* strain SD1^T^; C, *A. marseillensis* strain Marseille-P2818; D, *A. mediterranea* strain Marseille-P3257; E, *A. oralis* strain Marseille-P3109; F, *A. urinae* strain Marseille-P2225; G, *A. oricola* strain CIP 107639T; H, *A. gerencseriae* strain CIP 105418T; I, *A. naeslundii* strain CIP 103128T; J, *A. timonensis* strain 7400942T; K, *A. massiliensis* strain 4401292T.

[^3]: +, positive result; −, negative result; w, weakly positive result; NA, data not available.

[^4]: A, *Actinomyces bouchesdurhonensis* strain Marseille-P2825; B, *A. ihuae* strain SD1^T^; C, *A. marseillensis* strain Marseille-P2818; D, *A. mediterranea* strain Marseille-P3257; E, *A. oralis* strain Marseille-P3109; F, *A. urinae* strain Marseille-P2225.

[^5]: TR, trace amounts \<1%.

[^6]: Mean peak area percentage ± standard deviation.

[^7]: A, *Actinomyces bouchesdurhonensis* strain Marseille-P2825; B, *A. ihuae* strain SD1^T^; C, *A. marseillensis* strain Marseille-P2818; D, *A. mediterranea* strain Marseille-P3257; E, *A. oralis* strain Marseille-P3109; F, *A. urinae* strain Marseille-P2225.

[^8]: I, indeterminate; R, resistant; S, susceptible; IMC, inhibitory minimal concentration.

[^9]: A, *Actinomyces bouchesdurhonensis* strain Marseille-P2825; B, *A. ihuae* strain SD1^T^; C, *A. marseillensis* strain Marseille-P2818; D, *A. mediterranea* strain Marseille-P3257; E, *A. oralis* strain Marseille-P3109; F, *A. urinae* strain Marseille-P2225.

[^10]: COGs, Clusters of Orthologous Groups database.

[^11]: Total is based on either size of genome (bp) or total number of protein-coding genes in annotated genome.

[^12]: A, *Actinomyces bouchesdurhonensis* strain Marseille-P2825; B, *A. ihuae* strain SD1^T^; C, *A. marseillensis* strain Marseille-P2818; D, *A. mediterranea* strain Marseille-P3257; E, *A. oralis* strain Marseille-P3109; F, *A. urinae* strain Marseille-P2225.

[^13]: COGs, Clusters of Orthologous Groups database.

[^14]: Total is based on either size of genome (bp) or total number of protein-coding genes in annotated genome.

[^15]: INSDC, International Nucleotide Sequence Database Collaboration.

[^16]: A, *Actinomyces bouchesdurhonensis* strain Marseille-P2825; B, *A. ihuae* strain SD1^T^; C, *A. marseillensis* strain Marseille-P2818; D, *A. mediterranea* strain Marseille-P3257; E, *A. oralis* strain Marseille-P3109; F, *A. urinae* strain Marseille-P2225; G, *A. cardiffensis*; H, *A. europaeus*; I, *A. johnsonii*; J, *A. naeslundii*; K, *A. odontolyticus.*

[^17]: dDDH, digital DNA-DNA hybridization; GGDC, genome-to-genome distance; HSP, high-scoring pair.

[^18]: Confidence intervals indicate inherent uncertainty in estimating DDH values from intergenomic distances based on models derived from empirical test data sets (which are always limited in size). These results are in accordance with 16S rRNA ([Fig. 1](#fig1){ref-type="fig"}) and phylogenetic analyses as well as GGDC results.
